Trials / Completed
CompletedNCT01926990
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Developing Non-Invasive Early Therapeutic Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial studies perfusion computed tomography (CT) in predicting response to treatment in patients with advanced kidney cancer. Comparing results of diagnostic procedures done before, during, and after targeted therapy may help doctors predict a patient's response to treatment and help plan the best treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | perfusion computed tomography | Undergo perfusion CT |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2018-07-16
- Completion
- 2021-12-17
- First posted
- 2013-08-21
- Last updated
- 2022-02-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01926990. Inclusion in this directory is not an endorsement.